Your browser doesn't support javascript.
loading
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.
Cardinale, Daniela; Ciceri, Fabio; Latini, Roberto; Franzosi, Maria Grazia; Sandri, Maria Teresa; Civelli, Maurizio; Cucchi, GianFranco; Menatti, Elisabetta; Mangiavacchi, Maurizio; Cavina, Raffaele; Barbieri, Enrico; Gori, Stefania; Colombo, Alessandro; Curigliano, Giuseppe; Salvatici, Michela; Rizzo, Antonio; Ghisoni, Francesco; Bianchi, Alessandra; Falci, Cristina; Aquilina, Michele; Rocca, Andrea; Monopoli, Anna; Milandri, Carlo; Rossetti, Giuseppe; Bregni, Marco; Sicuro, Marco; Malossi, Alessandra; Nassiacos, Daniele; Verusio, Claudio; Giordano, Monica; Staszewsky, Lidia; Barlera, Simona; Nicolis, Enrico B; Magnoli, Michela; Masson, Serge; Cipolla, Carlo M.
Afiliación
  • Cardinale D; Cardioncology Unit, European Institute of Oncology, Milano, Italy.
  • Ciceri F; Haematology/Transplant Unit, Istituto Scientifico H. San Raffaele, Milano, Italy.
  • Latini R; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy. Electronic address: roberto.latini@marionegri.it.
  • Franzosi MG; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Sandri MT; Laboratory Medicine Division, European Institute of Oncology, Milano, Italy.
  • Civelli M; Cardioncology Division, European Institute of Oncology, Milano, Italy.
  • Cucchi G; Cardiology, Ospedale di Sondrio, Italy.
  • Menatti E; Oncology, Ospedale di Sondrio, Italy.
  • Mangiavacchi M; Cardiology, Istituto Clinico Humanitas, Rozzano, Italy.
  • Cavina R; Oncology, Istituto Clinico Humanitas, Rozzano, Italy.
  • Barbieri E; Cardiology, Ospedale Sacro Cuore, Negrar, Italy.
  • Gori S; Oncology, Ospedale Sacro Cuore, Negrar, Italy.
  • Colombo A; Cardioncology Unit, European Institute of Oncology, Milano, Italy.
  • Curigliano G; Division of Early Drug Development for Innovative Therapy, Department of Oncology and Hemato-Oncology, University of Milano, European Institute of Oncology, Milano, Italy.
  • Salvatici M; Laboratory Medicine Division, European Institute of Oncology, Milano, Italy.
  • Rizzo A; Cardiology, Ospedale di Vaio, Fidenza, Italy.
  • Ghisoni F; Unità Operativa Complessa Cure Palliative, Ospedale di Vaio, Fidenza, Italy.
  • Bianchi A; Cardiology, Istituto Oncologico Veneto, Padova, Italy.
  • Falci C; Oncology, Istituto Oncologico Veneto, Padova, Italy.
  • Aquilina M; Cardiology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRCCS, Meldola, Italy.
  • Rocca A; Oncology, IRCCS-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
  • Monopoli A; Cardiology, Nuovo Ospedale San Giuseppe, Empoli, Italy.
  • Milandri C; Oncology, Nuovo Ospedale San Giuseppe, Empoli, Italy.
  • Rossetti G; Cardiology, Presidio Ospedaliero di Busto Arsizio, Italy.
  • Bregni M; Oncology, Presidio Ospedaliero di Busto Arsizio, Italy.
  • Sicuro M; Cardiology, Ospedale Regionale Umberto Parini, Aosta, Italy.
  • Malossi A; Oncology, Ospedale Regionale Umberto Parini, Aosta, Italy.
  • Nassiacos D; Cardiology, Presidio Ospedaliero di Saronno, Saronno, Italy.
  • Verusio C; Oncology, Presidio Ospedaliero di Saronno, Saronno, Italy.
  • Giordano M; Oncology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy.
  • Staszewsky L; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Barlera S; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Nicolis EB; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Magnoli M; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Masson S; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Cipolla CM; Cardioncology Division, European Institute of Oncology, Milano, Italy.
Eur J Cancer ; 94: 126-137, 2018 05.
Article en En | MEDLINE | ID: mdl-29567630
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Enalapril / Disfunción Ventricular Izquierda / Troponina C / Antineoplásicos Tipo de estudio: Clinical_trials / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Enalapril / Disfunción Ventricular Izquierda / Troponina C / Antineoplásicos Tipo de estudio: Clinical_trials / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Italia